Adult ADHD Registry
Summary
The Neurocognitive Disorders Lab at the University of Calgary is creating a Registry of adults in the Calgary area who have ADHD, or suspect that they may have ADHD. The purpose of this Registry is to create a pool of individuals who may be interested in participating in future ADHD research. If you sign up with the ADHD Registry, you may be contacted in the future to ask if you are willing to participate in one or more research studies related to ADHD. You will be able to withdraw your participation from the Registry at any time by contacting the researchers.
Sign up for the registry directly here: http://bit.ly/ADHDregistry.
Eligibility
Eligible ages: 18 to 100
Accepts healthy participants: Yes
Inclusion criteria:
We are looking for individuals who:
1) Are at least 18 years old
2) Are fluent in English
3) Have been diagnosed with ADHD, or suspect that they may have ADHD
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Sign up for the registry directly here: http://bit.ly/ADHDregistry. For more information, please contact Brandy Callahan at brandy.callahan@ucalgary.ca
Principal investigator:
Brandy Callahan
Clinical trial:
No
REB-ID:
REB20-1864